Morgan & Morgan Announces the Investigation of Chemed Corporation (NYSE: CHE)

NEW YORK, May 8, 2013 /PRNewswire/ -- Morgan & Morgan announces that it is investigating possible securities law violations by Chemed Corporation ("Chemed" or the "Company") (NYSE: CHE) following the U.S. Department of Justice's ("DOJ") filing of a lawsuit alleging that Chemed's Vitas Hospice units ("Vitas") knowingly overbilled the Government's Medicare program.   

If you purchased Chemed and want more information about the Chemed securities fraud class action, please contact George Pressly, Esq. at 1 (800) 631-6234 or email George at [email protected].

Specifically, the DOJ complaint alleges that Chemed and Vitas (collective, the "companies") knowingly submitted, or caused the submission of, false claims to Medicare for crisis care services that were either not necessary, not actually provided, or not performed in accordance with Medicare requirements.   According to the DOJ's complaint, the companies allegedly used aggressive marketing tactics and pressured staff to increase the numbers of crisis care claims submitted to Medicare without regard to whether the services were appropriate or were actually being provided.  In addition, the DOJ alleges that the companies knowingly submitted, or caused the submission, of false claims for hospice care for patients who were not terminally ill.    

As a result of the conduct alleged in the DOJ complaint, the government contends that the companies violated the False Claims Act and misspent tens of millions of taxpayer dollars from the Medicare program.

Morgan & Morgan's investigation is focused on the time period between May 2, 2008 and May 2, 2013 to determine primarily whether Chemed or its officers and directors violated the federal securities laws by artificially and materially inflating its financial results. 

Morgan & Morgan

Morgan & Morgan is one of the nation's largest 200 law firms. In addition to securities fraud, the firm also practices in the areas of antitrust, consumer class actions, personal injury, consumer protection, overtime, and product liability.  All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people." 

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44^th Street
Suite 2001
New York, NY  10036
1-800-631-6234
[email protected]

SOURCE Morgan & Morgan

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED